Trial Profile
Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis - Pilot Phase (ATTEST).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Tenecteplase (Primary) ; Alteplase
- Indications Stroke
- Focus Therapeutic Use
- Acronyms ATTEST
- 19 Mar 2021 Systemic review and meta-analysis this and 3 other studies (EXTEND-IA, AUSTRALIAN TNK & TAAIS), presented at the International Stroke Conference 2021.
- 04 Dec 2020 Results comparing the efficacy and safety outcomes of intravenous tenecteplase to intravenous alteplase administration for acute ischemic stroke patients with large vessel occlusions from 4 trials, published in the Stroke
- 13 Dec 2016 Results of pooled post-hoc analysis from TAAIS and ATTEST studies (n=146) published in the Circulation.